PE26691A1 - Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas - Google Patents

Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas

Info

Publication number
PE26691A1
PE26691A1 PE1991185432A PE18543291A PE26691A1 PE 26691 A1 PE26691 A1 PE 26691A1 PE 1991185432 A PE1991185432 A PE 1991185432A PE 18543291 A PE18543291 A PE 18543291A PE 26691 A1 PE26691 A1 PE 26691A1
Authority
PE
Peru
Prior art keywords
asthma
arthritis
useful
treatment
azabencimidazoles
Prior art date
Application number
PE1991185432A
Other languages
English (en)
Spanish (es)
Inventor
Anthony Marfat
James Frederick Eggler
Michael Jonathan Fray
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE26691A1 publication Critical patent/PE26691A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PE1991185432A 1990-05-09 1991-05-08 Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas PE26691A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
PE26691A1 true PE26691A1 (es) 1991-10-21

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1991185432A PE26691A1 (es) 1990-05-09 1991-05-08 Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas

Country Status (28)

Country Link
EP (1) EP0533695B1 (en, 2012)
JP (1) JPH0678340B2 (en, 2012)
CN (1) CN1057839A (en, 2012)
AP (1) AP224A (en, 2012)
AT (1) ATE112567T1 (en, 2012)
AU (1) AU642265B2 (en, 2012)
BG (1) BG97059A (en, 2012)
BR (1) BR9106433A (en, 2012)
CA (1) CA2080476A1 (en, 2012)
DE (1) DE69104481T2 (en, 2012)
DK (1) DK0533695T3 (en, 2012)
ES (1) ES2061247T3 (en, 2012)
FI (1) FI925053A0 (en, 2012)
GT (1) GT199100031A (en, 2012)
HU (1) HUT62894A (en, 2012)
IE (1) IE911553A1 (en, 2012)
IL (1) IL98075A0 (en, 2012)
MA (1) MA22151A1 (en, 2012)
MY (1) MY105512A (en, 2012)
NO (1) NO924290D0 (en, 2012)
NZ (1) NZ238089A (en, 2012)
PE (1) PE26691A1 (en, 2012)
PT (1) PT97616A (en, 2012)
RO (1) RO109450B1 (en, 2012)
TW (1) TW205549B (en, 2012)
WO (1) WO1991017163A1 (en, 2012)
YU (1) YU81191A (en, 2012)
ZA (1) ZA913497B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
CN1308622A (zh) * 1998-05-12 2001-08-15 美国家用产品公司 用于治疗胰岛素抗性和高血糖的联苯基氧代－乙酸
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
JP2016537398A (ja) * 2013-09-13 2016-12-01 コーテンドー エービー（ピーユービーエル）Ｃｏｒｔｅｎｄｏ Ａｂ（Ｐｕｂｌ） 新規なチトクロムｐ４５０阻害剤及びこれらの使用方法
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
FI925053L (fi) 1992-11-06
RO109450B1 (ro) 1995-02-28
HUT62894A (en) 1993-06-28
MA22151A1 (fr) 1991-12-31
EP0533695B1 (en) 1994-10-05
WO1991017163A1 (en) 1991-11-14
GT199100031A (es) 1992-10-30
IE911553A1 (en) 1991-11-20
HU9203496D0 (en) 1993-01-28
IL98075A0 (en) 1992-06-21
ZA913497B (en) 1992-12-30
JPH05505619A (ja) 1993-08-19
MY105512A (en) 1994-10-31
DK0533695T3 (da) 1995-01-09
AP224A (en) 1992-10-27
AU7867191A (en) 1991-11-27
AP9100259A0 (en) 1991-07-31
EP0533695A1 (en) 1993-03-31
CA2080476A1 (en) 1991-11-10
CN1057839A (zh) 1992-01-15
BR9106433A (pt) 1993-05-04
DE69104481T2 (de) 1995-02-09
FI925053A7 (fi) 1992-11-06
ATE112567T1 (de) 1994-10-15
YU81191A (sh) 1994-06-10
TW205549B (en, 2012) 1993-05-11
NO924290L (no) 1992-11-06
NO924290D0 (no) 1992-11-06
NZ238089A (en) 1992-10-28
JPH0678340B2 (ja) 1994-10-05
PT97616A (pt) 1992-03-31
BG97059A (bg) 1993-12-24
DE69104481D1 (de) 1994-11-10
AU642265B2 (en) 1993-10-14
ES2061247T3 (es) 1994-12-01
FI925053A0 (fi) 1992-11-06

Similar Documents

Publication Publication Date Title
ES2012527A6 (es) Procedimiento de obtencion de benzo(b) piranos y piranopiridinas.
ES2086505T3 (es) Procedimiento de preparacion de un derivado n-fenilacetico de tetrahidrotieno(3,2-c)piridina y su producto intermedio de sintesis.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
ES2060883T3 (es) Procedimiento de obtencion del acido carnosico.
ES8706164A1 (es) Un procedimiento para la preparacion de glicosidos de homo- nojirimicina
ATE57946T1 (de) Schlagzaehe polyamid-formmassen.
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
ES2137932T3 (es) Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina.
DE3380409D1 (de) Diazabicyclo(3.3.1)nonanes
ES2089416T3 (es) Procedimiento de produccion de intermedios para uso en la produccion de alcoxiiminoacetamidas.
PE26691A1 (es) Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas
ES2109545T3 (es) Benzoilguanidina sustituida, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico asi como el medicamento que la contiene.
PE20010328A1 (es) Analogos de vitamina d3
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES2078749T3 (es) Procedimiento para preparar sertralina.
ES2109229T3 (es) Sulfonamidas sustituidas y compuestos relacionados para el tratamiento del asma, la artritis y enfermedades relacionadas.
ES2060127T3 (es) Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.
ES2074508T3 (es) Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos.
ES8107199A1 (es) Un procedimiento para la preparacion de nuevos 1,2,4-triazo-les
ES2143973T3 (es) Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos.
UY24009A1 (es) Compuestos ariltio útiles como agentes antivirales y antibacteriales
ES2062407T3 (es) Compuestos de 2-hidroxi-3-fenoxipropilamino.
ES8203824A1 (es) Procedimiento para preparar esteres de 2-nitro-5-fenoxi sustituido)benzoato de alfa-hidroxialcanoatos
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.